We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Nicolai Franzmeier

Nicolai Franzmeier PhD

Junior Research Group Leader, Institute for Stroke and Dementia Research, LMU University Hospital, Munich, Germany

Nicolai Franzmeier, PhD, is an early career investigator with a strong focus on Alzheimer’s disease (AD) neuroimaging research. He received undergraduate training in psychology and medicine from 2009-2014 in Innsbruck, Austria, after which he completed hisPhD at the graduate school for systemic neurosciences (LMU) in Munich in 2017. 

Dr. Franzmeier is specifically interested in the 1) spatiotemporal evolution of AD-related brain changes that underlie cognitive decline and 2) those factors that provide resilience in AD. His overall goal is to develop clinically useful models for predicting disease progression and to identify therapeutically relevant targets for secondary prevention of AD dementia. To this end, he is combining structural & functional MRI with molecular PET imaging and genetics.

Disclosures

Dr. Franzmeier has no relevant disclosures.